Cargando…
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals
Allergen specific CD4+ T cell clones generated from allergic individuals have been shown to produce increased levels of the cytokine interleukin 4 (IL-4), compared to allergen specific clones generated from nonallergic individuals. This difference between CD4+ T cells from allergic and nonallergic i...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191292/ https://www.ncbi.nlm.nih.gov/pubmed/7902409 |
Ejemplares similares
-
Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type
Publicado: (1995) -
Allergic asthma: An indication for allergen immunotherapy
por: Ankermann, Tobias, et al.
Publicado: (2023) -
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020) -
Anti-Interleukin-9 Antibody Increases the Effect of Allergen-Specific Immunotherapy in Murine Allergic Rhinitis
por: Shin, Ji-Hyeon, et al.
Publicado: (2017) -
Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)